-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to reports from the National Lung Screening Trial and European Randomized Trials, the use of low-dose computed tomography (LDCT) for lung cancer screening (LCS) can reduce lung cancer mortality.
Screening diagnosis
Recently, a study published in the journal European Radiology evaluated the computer-assisted low-dose chest CT (LDCTs) of radiologists in the nationwide lung cancer screening (LCS) program by comparing with the retrospective analysis of the central laboratory.
The continuous baseline LDCT from the national LCS plan was studied (n = 3353).
In institutional reading, the positive rate of radiologists for Lung-RADS was between 7.
An example of inconsistent interpretation between the agency reading and the review of the central laboratory.
Despite the use of computer reading systems, there are considerable differences in the judgments of low-dose chest CT screening in lung cancer screening projects across the country.
Original source:
Eui Jin Hwang,Jin Mo Goo,Hyae Young Kim,et al.
